Day: August 5, 2021

KalGene Pharmaceuticals Inc. an Alzheimer’s focused company using a next generation engineered drug candidate, has appointed new leadership

Mr. Anthony J. Giovinazzo joins as Executive Chairman; and Dr. Nickolay V. Kukekov, Ph.D. as President and CEO KalGene also announced that concurrent with the appointment of new leadership, the Company has closed on a substantial amount of capital from US institutions and family offices to progress KG207 to clinical testing MONTREAL and TORONTO, Aug. 5, 2021 […]

Bombardier Raises Full Year Guidance Following Solid First Half Execution and Market Momentum, Reports Second Quarter 2021 Results

Raised FY2021 guidance: (i) aircraft deliveries expected to reach ~120 units, revenues to exceed $5.8B; (ii) profitability increased to greater than $175M adjusted EBIT(1) and adjusted EBITDA(1) expected to be greater than $575M vs previously announced $100M and $500M, respectively; (iii) Free cash flow usage(1) now expected to be better than $300M for the year vs $500M(2) Business […]